Search

C14H18N8O8SnCl6, monoclinic, P21/n (no. 14), a = 8.1810(2) Å, b = 12.6195(3) Å, c = 11.3811(2) Å, β = 90.258(2)°, Z = 2, V = 1174.97(5) Å3, Rgt(F) = 0.0266, wRref = 0.0620, T = 290 K.

C10H16I4ZnN2, monoclinic, P21 (no. 4), a = 7.3340(1) Å, b = 14.4781(3) Å, c = 8.6768(2) Å, β = 94.919(2)°, V = 917.93(3) Å3, Z = 2, Rgt(F) = 0.0165, wRref(F2) = 0.0397, T = 110 K.

C13H17Cl2NO2, triclinic, P1 (no. 1), a = 7.1486(3) Å, b = 7.8265(3) Å, c = 13.6579(5) Å, α = 81.085(3)°, β = 77.487(4)°, γ = 73.335(4)°, Z = 2, V = 711.13(5) Å3, Rgt(F) = 0.0536, wRref = 0.0878, T = 290 K.

C8H14Br2N2, monoclinic, I2/a (no. 15), a = 9.0331(9) Å, b = 13.4475(14) Å, c = 27.586(3) Å, β = 94.879(9)°, Z = 12, V = 3338.8(6) Å3, Rgt(F) = 0.0582, wRref = 0.0885, T = 290 K.

C34H57BBr6N6O4V2, orthorhombic, Pna21 (no. 33), a = 17.198(2) Å, b = 12.9497(11) Å, c = 20.496(2) Å, V = 4564.8(9) Å3, Z = 4, Rgt(F) = 0.0441, wRref(F2) = 0.1093, T = 183(2) K.

C13H16ClNO2, monoclinic, P21 (no. 4), a = 7.4945(7) Å, b = 7.2336(6) Å, c = 11.5401(10) Å, β = 92.555(2)°, V = 624.99(10) Å3, Z = 2, Rgt(F) = 0.0415, wRref(F2) = 0.0947, T = 291 K.

In the asymmetric unit of the title salt, C3H9S+·CH2B11FI10N− or (CH3)3S[1-H2N-6-F-closo-1-CB11I10], both ions lie in general positions. The anion is perfectly ordered and so the positions of the C—NH2 vertex and the fluorine substituent are clearly assigned. The relatively short C—N bond length may be interpreted in terms of a very electron deficient {closo-1-CB11} cluster.

The asymmetric unit of the title compound, C₁₂H ₁₈F₄Si₂, contains two independent mol-ecules, both lying on inversion centers. The Carene-Si distances are significantly longer than in the analogous non-fluorinated compound. The packing of the mol-ecules results in a herringbone motif in the ac plane.